Cure My Disease

Don't miss your cure!

 Log in / Sign up

Phone support eases pregnancy anxiety, study finds

NCT ID NCT07507721

Symptom relief Sponsor: Abant Izzet Baysal University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 07, 2026 · Updated 2 times

Summary

This study looks at whether adding nurse phone support to a simple daily baby-movement awareness practice (Mindfetalness) helps pregnant women feel less anxious and more bonded with their baby. About 68 first-time mothers in their 28th week of pregnancy will practice Mindfetalness for 15 minutes each day for 8 weeks. Half will also get regular nurse calls. The study measures anxiety and attachment levels at the start, 4 weeks, and 8 weeks.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 68 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2026

Expected to finish

Apr 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Aged 18 years or older * Being at the 28th week of gestation * Having a singleton pregnancy * Being primiparous * Being literate * Having access to and the ability to use a mobile device and internet connection (personal or via spouse) compatible with the tele-nursing application * Volunteering to participate in the study and providing informed consent (Araştırmaya katılmaya gönüllü olmak ve bilgilendirilmiş onam vermek) Exclusion Criteria: * Having a high-risk pregnancy (e.g., preterm labor threat, preeclampsia, gestational diabetes, placenta previa, or cardiac disease). * Presence of diagnosed fetal health complications (e.g., intrauterine growth restriction \[IUGR\], fetal anomalies). * Currently monitoring fetal movements using any other conventional fetal movement counting methods. * Presence of any communication barriers (e.g., hearing, speech, or language impairments). * History or current diagnosis of chronic or psychiatric illness. * Conception through assisted reproductive techniques (ART) (e.g., IVF).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Fetal movement are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Fetal movement Tele-nursing

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Abant Izzet Baysal University Izzet Baysal Training and Research Hospital

    RECRUITING

    Bolu, 14030, Turkey (Türkiye)

  • Bolu Abant Izzet Baysal University

    NOT_YET_RECRUITING

    Bolu, 14030, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.